Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

February 2017; Volume 37,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, KENSAKU

    1. You have access
      Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone
      MAMER ROSARIO, AKIHIKO TAKEUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI, HISAKI AIBA, YOSHIKAZU TANZAWA, HIDEKI MURAKAMI and HIROYUKI TSUCHIYA
      Anticancer Research February 2017, 37 (2) 749-754;
  2. Ablin, RICHARD J.

    1. You have access
      Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
      RICHARD J. ABLIN, SIONED OWEN and WEN G. JIANG
      Anticancer Research February 2017, 37 (2) 481-487;
  3. Adekoya, DEBBIE

    1. You have access
      Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells
      SEYUNG S. CHUNG, DEBBIE ADEKOYA, IKECHUKWU ENENMOH, ORETTE CLARKE, PIWEN WANG, MARIANNA SARKYSSIAN, YONG WU and JAYDUTT V. VADGAMA
      Anticancer Research February 2017, 37 (2) 445-453;
  4. Agarwal, MANUJ

    1. You have access
      Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the “QUAD-SHOT Regimen”
      MAURICIO E. GAMEZ, MANUJ AGARWAL, KENNETH S. HU, JOHN N. LUKENS and LOUIS B. HARRISON
      Anticancer Research February 2017, 37 (2) 685-691;
  5. Agolli, LINDA

    1. You have access
      Mono- and Bi-weekly Hypofractionated Radiation Therapy for the Treatment of Epithelial Skin Cancer in Very Elderly Patients
      MAURIZIO VALERIANI, LUCA NICOSIA, LINDA AGOLLI, CHIARA REVERBERI, EMANUELA GALVAGNO, VITALIANA DE SANCTIS, GIUSEPPE MINNITI, MARTA CARLESIMO and MATTIA F. OSTI
      Anticancer Research February 2017, 37 (2) 825-830;
  6. Ahn, SOON-HYUN

    1. You have access
      HIF1α in Tumorigenesis of Adenoid Cystic Carcinoma
      YUN-SUNG LIM, WONJAE CHA, MIN-WOO PARK, WOO-JIN JEONG and SOON-HYUN AHN
      Anticancer Research February 2017, 37 (2) 599-606;
  7. Aiba, HISAKI

    1. You have access
      Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone
      MAMER ROSARIO, AKIHIKO TAKEUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI, HISAKI AIBA, YOSHIKAZU TANZAWA, HIDEKI MURAKAMI and HIROYUKI TSUCHIYA
      Anticancer Research February 2017, 37 (2) 749-754;
  8. Aizawa, TAKUYA

    1. You have access
      Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy
      MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA, NAOYA ISHIBASHI and TSUTOMU SAITO
      Anticancer Research February 2017, 37 (2) 941-947;
  9. Akamine, TAKAKI

    1. You have access
      Radiological Features of the Surgically Resected Small-sized Small-cell Lung Cancer on Computed Tomography
      GOUJI TOYOKAWA, YUKA KOZUMA, TAICHI MATSUBARA, NAOKI HARATAKE, SHINKICHI TAKAMORI, TAKAKI AKAMINE, KAZUKI TAKADA, MASAKAZU KATSURA, FUMIHIRO SHOJI, TATSURO OKAMOTO and YOSHIHIKO MAEHARA
      Anticancer Research February 2017, 37 (2) 877-881;
    2. You have access
      The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer
      FUMIHIRO SHOJI, NAOKI HARATAKE, TAKAKI AKAMINE, SHINKICHI TAKAMORI, MASAKAZU KATSURA, KAZUKI TAKADA, GOUJI TOYOKAWA, TATSURO OKAMOTO and YOSHIHIKO MAEHARA
      Anticancer Research February 2017, 37 (2) 741-747;
  10. Al-abadi, HUSSEIN

    1. You have access
      DNA Cytometry for Differentiation Between Low- and Medium-grade Dysplasia in Intraductal Papillary Mucinous Neoplasms
      FRITZ KLEIN, TIMM DENECKE, WLADIMIR FABER, CHRISTIAN JÜRGENSEN, ANJA SCHIRMEIER, HUSSEIN AL-ABADI, THULA C. WALTER, NADINE AL-ABADI, THOMAS MALINKA, JOHANN PRATSCHKE and MARCUS BAHRA
      Anticancer Research February 2017, 37 (2) 735-740;
« Previous (Pages : 1 2 3 4 5 6 ... 57) Next »
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 37, Issue 2
February 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire